Zylkiewicz, E., Rzymski, T., Mikula, M., Dreas, A., Wiklik, K., Wrobel, A., Golas, A., Dolata, I., Wojcik, K., Masiejczyk, M., Statkiewicz, M., Kuklinska, U., Goryca, K., Grochowsk, A., Cabaj, A., Bialas, A., Mikulski, M., Windak, R., Ostrowski, J., & Brzozka, K. (n.d.). sEL120–34A, a specific, potent and orally bioavailable inhibitor of CDK8, targets STAT-dependent gene transcription in leukemia and lymphoma models. European journal of cancer, 69, S132–. http://access.bl.uk/ark:/81055/vdc_100039473461.0x000035